Richard W. Paul & Associates’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2
| Closed | -$23 | – | 458 |
|
|
2024
Q4 | $23 | Hold |
2
| – | – | ﹤0.01% | 508 |
|
|
2024
Q3 | $41 | Hold |
2
| – | – | ﹤0.01% | 499 |
|
|
2024
Q2 | $45 | Hold |
2
| – | – | ﹤0.01% | 490 |
|
|
2024
Q1 | $55 | Hold |
2
| – | – | ﹤0.01% | 504 |
|
|
2023
Q4 | $61 | Hold |
2
| – | – | ﹤0.01% | 492 |
|
|
2023
Q3 | $63 | Sell |
2
-2
| -50% | -$63 | ﹤0.01% | 501 |
|
|
2023
Q2 | $163 | Sell |
4
-6
| -60% | -$245 | ﹤0.01% | 520 |
|
|
2023
Q1 | $373 | Hold |
10
| – | – | ﹤0.01% | 513 |
|
|
2022
Q4 | $349 | Buy |
+10
| New | +$349 | ﹤0.01% | 505 |
|